Live Quote · NASDAQCOLLHealthcare· Drug Manufacturers - Specialty & Generic

Collegium Pharmaceutical, Inc.

$37.03 3.23%(+$1.16)
TickerSpark Score
68/100
Solid
90
Valuation
85
Profitability
50
Growth
64
Health
50
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a COLL research report →

52-Week Range36% of range
Low
$29.19
Current
$37.03
High
$50.79
Company Overviewwww.collegiumpharma.com

About the company

Collegium Pharmaceutical, Inc. (COLL) is a specialized pharmaceutical firm dedicated to the development and marketing of medications for pain management. Its diverse product lineup features significant therapies aimed at addressing various pain conditions.

CEO
Vikram Karnani
IPO
2015
Employees
357
HQ
Stoughton, MA, US

Price Chart

+21.37% · this period
$49.84$39.80$29.75Jul 02Dec 31Jul 02
Valuation
Market Cap
$1.20B
P/E
15.62
P/S
1.51
P/B
3.80
EV/EBITDA
2.85
Div Yield
0.00%
Profitability
Gross Margin
60.68%
Op Margin
23.85%
Net Margin
9.41%
ROE
26.74%
ROIC
10.51%
Growth & Income
Revenue
$780.57M · 23.62%
Net Income
$62.87M · -9.13%
EPS
$1.98 · -7.48%
Op Income
$187.08M
FCF YoY
61.11%
Performance & Tape
52W High
$50.79
52W Low
$29.19
50D MA
$34.30
200D MA
$39.20
Beta
0.75
Avg Volume
460.85K

Get TickerSpark's AI analysis on COLL

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

DateInsiderTypeShares
Jun 8, 26SANTINI GINOother8,700
Jun 8, 26SANTINI GINOother8,700
May 18, 26Freund John Gordonsell20
May 14, 26Lurker Nancyother8,741
May 14, 26Paya Carlos Vother8,741
May 15, 26Freund John Gordonother8,700
May 15, 26Freund John Gordonsell4,127
May 14, 26Freund John Gordonother8,741
May 15, 26Freund John Gordonother8,700
May 14, 26BOHLIN GAREN Gother8,741
Coverage · COLL

Our COLL coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on COLL yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate COLL report →
Internal Compare

Similar companies

Peers in the same neighborhood.